Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109

Cancers (Basel). 2022 Sep 19;14(18):4525. doi: 10.3390/cancers14184525.

Dongyu Zhang^{1

2}, Neil J Shah³, Michael Cook⁴, Matthew Blackburn⁴, Michael T Serzan⁴, Shailesh Advani^{5

6}, Arnold L Potosky⁷, Subha Madhavan^{7

8}, Anas Belouali^{7

8}, Michael B Atkins^{5

7}, Dejana Braithwaite^{1

2

9}

¹ Department of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, USA.
² University of Florida Health Cancer Center, Gainesville, FL 32610, USA.
³ Department of Medicine, Solid Tumor Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
⁴ Department of Medicine, Division of Hematology/Oncology MedStar Georgetown University Hospital, Washington, DC 20007, USA.
⁵ Department of Oncology, School of Medicine, Georgetown University, Washington, DC 20007, USA.
⁶ Transplant Education Research Center, Terasaki Institute of Biomedical Innovation, Los Angeles, CA 90024, USA.
⁷ Georgetown Lombardi Comprehensive Cancer Center, Washington, DC 20057, USA.
⁸ Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC 20007, USA.
⁹ Department of Surgery, University of Florida, Gainesville, FL 32610, USA.

Abstract

Subha Madhavan (S.M.) and Anas Belouali (A.B.) were not included as authors in the published article [...].